342 related articles for article (PubMed ID: 23586391)
1. Effect of the hydrogen sulfide donor GYY4137 on platelet activation and microvascular thrombus formation in mice.
Grambow E; Mueller-Graf F; Delyagina E; Frank M; Kuhla A; Vollmar B
Platelets; 2014; 25(3):166-74. PubMed ID: 23586391
[TBL] [Abstract][Full Text] [Related]
2. The effects of hydrogen sulfide on platelet-leukocyte aggregation and microvascular thrombolysis.
Grambow E; Leppin C; Leppin K; Kundt G; Klar E; Frank M; Vollmar B
Platelets; 2017 Jul; 28(5):509-517. PubMed ID: 27819526
[TBL] [Abstract][Full Text] [Related]
3. Acid sphingomyelinase regulates platelet cell membrane scrambling, secretion, and thrombus formation.
Münzer P; Borst O; Walker B; Schmid E; Feijge MA; Cosemans JM; Chatterjee M; Schmidt EM; Schmidt S; Towhid ST; Leibrock C; Elvers M; Schaller M; Seizer P; Ferlinz K; May AE; Gulbins E; Heemskerk JW; Gawaz M; Lang F
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):61-71. PubMed ID: 24233488
[TBL] [Abstract][Full Text] [Related]
4. Protective mechanisms of adenosine 5'-monophosphate in platelet activation and thrombus formation.
Fuentes E; Badimon L; Caballero J; Padró T; Vilahur G; Alarcón M; Pérez P; Palomo I
Thromb Haemost; 2014 Mar; 111(3):491-507. PubMed ID: 24306059
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen sulfide reduces the activity of human endothelial cells.
Grambow E; Klee G; Xie W; Schafmayer C; Vollmar B
Clin Hemorheol Microcirc; 2020; 76(4):513-523. PubMed ID: 32924989
[TBL] [Abstract][Full Text] [Related]
6. Activation of porcine endothelium in response to xenogeneic serum causes thrombosis independently of platelet activation.
Galbusera M; Buelli S; Gastoldi S; Macconi D; Angioletti S; Testa C; Remuzzi G; Morigi M
Xenotransplantation; 2005 Mar; 12(2):110-20. PubMed ID: 15693841
[TBL] [Abstract][Full Text] [Related]
7. Anti-oxidant ebselen delays microvascular thrombus formation in the rat cremaster muscle by inhibiting platelet P-selectin expression.
Lindenblatt N; Schareck W; Belusa L; Nickels RM; Menger MD; Vollmar B
Thromb Haemost; 2003 Nov; 90(5):882-92. PubMed ID: 14597984
[TBL] [Abstract][Full Text] [Related]
8. Protein phosphatase inhibitor calyculin-A modulates activation markers in TRAP-stimulated human platelets.
Simon Z; Kiss A; Erdödi F; Setiadi H; Beke Debreceni I; Nagy B; Kappelmayer J
Platelets; 2010; 21(7):555-62. PubMed ID: 20670106
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of platelet-mediated arterial thrombosis and platelet granule exocytosis by 3',4'-dihydroxyflavonol and quercetin.
Mosawy S; Jackson DE; Woodman OL; Linden MD
Platelets; 2013; 24(8):594-604. PubMed ID: 23249183
[TBL] [Abstract][Full Text] [Related]
10. The Marine-Derived Kinase Inhibitor Fascaplysin Exerts Anti-Thrombotic Activity.
Ampofo E; Später T; Müller I; Eichler H; Menger MD; Laschke MW
Mar Drugs; 2015 Nov; 13(11):6774-91. PubMed ID: 26569265
[TBL] [Abstract][Full Text] [Related]
11. GDF-15 prevents platelet integrin activation and thrombus formation.
Rossaint J; Vestweber D; Zarbock A
J Thromb Haemost; 2013 Feb; 11(2):335-44. PubMed ID: 23231375
[TBL] [Abstract][Full Text] [Related]
12. The slow releasing hydrogen sulfide donor GYY4137 reduces neointima formation upon FeCl3 injury of the carotid artery in mice.
Grambow E; Klee G; Klar E; Vollmar B
Clin Hemorheol Microcirc; 2020; 75(4):409-417. PubMed ID: 31929150
[TBL] [Abstract][Full Text] [Related]
13. The application of tetrahydroisoquinoline-3-carbonyl-TARGD(F)F as an anti-thrombotic agent having dual mechanisms of action.
Yang G; Zhu H; Zhao M; Wu J; Wang Y; Wang Y; Zheng M; Chen M; Liu J; Peng S
Mol Biosyst; 2012 Oct; 8(10):2672-9. PubMed ID: 22801714
[TBL] [Abstract][Full Text] [Related]
14. The anti-thrombotic effect of hydrogen sulfide is partly mediated by an upregulation of nitric oxide synthases.
Kram L; Grambow E; Mueller-Graf F; Sorg H; Vollmar B
Thromb Res; 2013 Aug; 132(2):e112-7. PubMed ID: 23916820
[TBL] [Abstract][Full Text] [Related]
15. Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules.
Ludwig RJ; Schultz JE; Boehncke WH; Podda M; Tandi C; Krombach F; Baatz H; Kaufmann R; von Andrian UH; Zollner TM
J Invest Dermatol; 2004 Mar; 122(3):830-6. PubMed ID: 15086572
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.
Karim ZA; Vemana HP; Alshbool FZ; Lin OA; Alshehri AM; Javaherizadeh P; Paez Espinosa EV; Khasawneh FT
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):637-44. PubMed ID: 25593131
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of caffeic acid on ADP-induced thrombus formation and platelet activation involves mitogen-activated protein kinases.
Lu Y; Li Q; Liu YY; Sun K; Fan JY; Wang CS; Han JY
Sci Rep; 2015 Sep; 5():13824. PubMed ID: 26345207
[TBL] [Abstract][Full Text] [Related]
18. Platelets enhance lymphocyte adhesion and infiltration into arterial thrombus.
Hu H; Zhu L; Huang Z; Ji Q; Chatterjee M; Zhang W; Li N
Thromb Haemost; 2010 Dec; 104(6):1184-92. PubMed ID: 20838746
[TBL] [Abstract][Full Text] [Related]
19. Platelets possess and require an active protein palmitoylation pathway for agonist-mediated activation and in vivo thrombus formation.
Sim DS; Dilks JR; Flaumenhaft R
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1478-85. PubMed ID: 17303775
[TBL] [Abstract][Full Text] [Related]
20. Dual inhibition of PI3K and mTOR by VS-5584 suppresses thrombus formation.
Später T; Müller I; Eichler H; Menger MD; Laschke MW; Ampofo E
Platelets; 2018 May; 29(3):277-287. PubMed ID: 28503993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
